Top 10 Rising Stocks To Own Right Now: Palatin Technologies Inc. (PTN)
Palatin Technologies, Inc., a biopharmaceutical company, engages in the development of peptide therapeutics for the treatment of diseases. Its drug development programs include Bremelanotide, a peptide melanocortin receptor agonist that is in Phase IIb clinical trials for the treatment of female sexual dysfunction; and PL-3994, a peptide mimetic natriuretic peptide receptor A agonist, which is in Phase I clinical trials for the treatment of cardiovascular and pulmonary indications, as well as melanocortin receptor-based compounds for treatment of obesity. The company was founded in 1986 and is based in Cranbury, New Jersey.
Advisors' Opinion:- [By James E. Brumley]
For the third time in a little more than three months I find myself singing the praises of Palatin Technologies, Inc. (NYSEMKT:PTN), suggesting it is a "buy" ... at least to nimble and cautious speculators. It's a rarity, as I tend not to like beating a dead horse (personal preference). PTN, however, is one of those rare cases where the message deserves to be delivered again, as there's still a lot of opportunity left for newcomers to tap into.
- [By James E. Brumley]
At first glance, Palatin Technologies, Inc. (NYSEMKT:PTN) doesn't look like anything particularly special, nor anything particularly investment-worthy. The longer you study the chart of PTN, however, the clearer it becomes... this stock is on the verge of breaking out, and should be on most traders' watchlists.
source from Top Stocks For 2015:http://www.topstocksblog.com/top-10-rising-stocks-to-own-right-now.html
No comments:
Post a Comment